1. Home
  2. HBB vs OSUR Comparison

HBB vs OSUR Comparison

Compare HBB & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$16.66

Market Cap

226.4M

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.40

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
OSUR
Founded
1904
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
226.4M
177.2M
IPO Year
2017
1986

Fundamental Metrics

Financial Performance
Metric
HBB
OSUR
Price
$16.66
$2.40
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
27.0K
742.3K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
3.02%
N/A
EPS Growth
24.53
N/A
EPS
2.34
N/A
Revenue
$607,430,000.00
$125,703,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.70
P/E Ratio
$6.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$2.08
52 Week High
$21.20
$4.22

Technical Indicators

Market Signals
Indicator
HBB
OSUR
Relative Strength Index (RSI) 53.46 43.86
Support Level $16.10 $2.41
Resistance Level $17.23 $2.53
Average True Range (ATR) 0.82 0.11
MACD -0.01 0.01
Stochastic Oscillator 43.72 15.52

Price Performance

Historical Comparison
HBB
OSUR

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: